drugset / Trial / NCT00322699
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Phase 1/2
Completed
22 enrolled
North Florida/South Georgia Veterans Health System
Axcan Pharma · collabNorth Florida Foundation for Research and Education · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This protocol is evaluating efficacy and toxicity of three sequential whole bladder photodynamic treatment with Photofrin and red laser light (630 nm) in the management of superficial bladder cancer (non-muscle invasive) in those patients who have failed or are not candidates for conventional intravesical therapy.
Timeline
- Start
- 2005-02
- Primary completion
- 2010-04
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | porfimer sodium | Small molecule | 1.5 mg/kg | Intravenous |